|
2025 Conference Publication YI6 MS outcomes in breast cancer survivors and the influence of chemotherapyNesbitt, Cassie, Sanfilippo, Paul, Zhu, Chao, Ozakbas, Serkan, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Kalincik, Tomas, Roos, Izanne, Buzzard, Katherine, Skibina, Olga, Foschi, Matteo, Surcinelli, Andrea, Boz, Cavit, Lechner-Scott, Jeannette, Libertinova, Jana, Patti, Francesco, Kermode, Allan, Pedrini, Marzena, Carroll, William, Barnett, Michael, Taylor, Bruce, Hodgkinson, Suzanne, Barnett, Michael, Mccombe, Pamela, Reddel, Stephen, Vucic, Steve, Ramanathan, Sudarshini, Macdonell, Richard ... Jokubaitis, Vilija (2025). YI6 MS outcomes in breast cancer survivors and the influence of chemotherapy. BMJ Publishing Group Ltd. doi: 10.1136/bmjno-2025-anzan.6 |
|
2025 Conference Publication YI5 Targeted nanopore long-read sequencing improves diagnosis of genetic myopathiesYeow, Dennis, Stevanovski, Igor, Reis, Andre LM, Rudaks, Laura I, Chintalaphani, Sanjog R, Grosz, Bianca, Liang, Christina, Morris, Katrina A, Reddel, Stephen, McCombe, Pamela A, Zhu, Danqing, Stoll, Marion, Davis, Ryan L, Manser, David, Tchan, Michel, Worgan, Lisa, Hannaford, Andrew, Sue, Carolyn M, Shandiz, Ehsan, Ahmad, Kate E, Ghaoui, Roula, Barnes, Stephanie L, Sturm, Jonathan, Willard, Anna, Hawke, Simon, Ng, Karl, Cheong, Pak Leng, Kennerson, Marina L, Kumar, Kishore R and Deveson, Ira W (2025). YI5 Targeted nanopore long-read sequencing improves diagnosis of genetic myopathies. BMJ Publishing Group Ltd. doi: 10.1136/bmjno-2025-anzan.5 |
|
2025 Conference Publication Preserving neurological function in people at high and low risk of aggressive multiple sclerosisRoos, Izanne, Sharmin, Sifat, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, Walt, Anneke van der, Butzkueven, Helmut, Barnett, Michael, Macdonell, Richard, John, Nevin, Hodgkinson, Suzanne, Slee, Mark, McCombe, Pamela, Garber, Justin, Kermode, Allan G., Fabis-Pedrini, Marzena J., Carroll, William M., Taylor, Bruce, Vukusic, Sandra and Kalincik, Tomas (2025). Preserving neurological function in people at high and low risk of aggressive multiple sclerosis. ANZAN Annual Scientific Meeting 2025, Sydney, NSW Australia, 23-26 June 2025. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2025-anzan.153 |
|
2025 Conference Publication Effectiveness of Horizontal Switching Between Disease-Modifying Therapies in Multiple SclerosisGomez Figueroa, Enrique, Orozco Puga, Patricia, Corona Vazquez, Cynthia, Moreno Bernardino, Carlos Javier, De la Mora Landin, Graciela, Jimenez-Ruiz, Amado, Garcia Estrada, Christian Alan, Zertuche-Ortuno, Lizeth, Saldivar Davila, Sergio, Rivas, Roberto Rodriguez, Bazan, Anna Lisette, Rivera, Jose Flores, Kalincik, Tomas, Buzzard, Katherine, Khoury, Samia, Duquette, Pierre, Foschi, Matteo, Surcinelli, Andrea, Weinstock-Guttman, Bianca, Gouider, Riadh, Mrabet, Saloua, Lechner-Scott, Jeannette, Butzkueven, Helmut, Alroughani, Raed, Roos, Izanne, Patti, Francesco, Spitaleri, Daniele, McCombe, Pamela, Sanchez Menoyo, Jose Luis ... Ruiz-Sandoval, Jose Luis (2025). Effectiveness of Horizontal Switching Between Disease-Modifying Therapies in Multiple Sclerosis. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Bayesian network to generate representative longitudinal data in multiple sclerosisQiang, Zhe, Iqbal, Hassam, Sharmin, Sifat, Ozakbas, Serkan, Zakaria, Magd Fouad, Etemadifar, Masoud, Alroughani, Raed, Boz, Cavit, Karabudak, Rana, Shaygannejad, Vahid, Habek, Mario, Terzi, Murat, Yamout, Bassem I., Khoury, Samia, Shalaby, Nevin, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Kermode, Allan, Pedrini, Marzena, Carroll, William, Horakova, Dana, Havrdova, Eva, Soysal, Aysun, Altintas, Ayse, Turkoglu, Recai, Gouider, Riadh, Mrabet, Saloua, Ayuso, Guillermo Izquierdo ... Kalincik, Tomas (2025). Bayesian network to generate representative longitudinal data in multiple sclerosis. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Real-world effectiveness of ocrelizumab in multiple sclerosis: a multi-registry observational cohort studyRoos, Izanne, Sharmin, Sifat, Horakova, Dana, Ozakbas, Serkan, Libertinova, Jana, Boz, Cavit, Alroughani, Raed, Barnett, Michael, van der Walt, Anneke, Butzkueven, Helmut, Rous, Zuzana, Mares, Miroslav, Buzzard, Katherine, Peterka, Marek, Scott, Jeannette Lechner, Foschi, Matteo, Surcinelli, Andrea, Hradilek, Pavel, Prevost, Julie, Brown, William, Eichau, Sara, Blanco, Yolanda, Terzi, Murat, Meca-Lallana, Jose E., Laureys, Guy, Grammond, Pierre, John, Nevin A., Soysal, Aysun, Ampapa, Radek ... Kalincik, Tomas (2025). Real-world effectiveness of ocrelizumab in multiple sclerosis: a multi-registry observational cohort study. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Disease-Modifying Treatment Cessation or Switch Due to Pregnancy Planning in Women with MS: Is It Safe?Hradilek, Pavel, Horakova, Dana, Drahota, Jiri, Mazouchova, Aneta, Havrdova, Eva, Vachova, Marta, Ampapa, Radek, Libertinova, Jana, Houskova, Jana, Recmanova, Eva, Dufek, Michal, Mares, Miroslav, Rous, Zuzana, Pavelek, Zbysek, Stetkarova, Ivana, Peterka, Marek, Stourac, Pavel, Mares, Jan, Alroughani, Raed, Ozakbas, Serkan, Karabudak, Rana, Boz, Cavit, Yammout, Bassem, Khoury, Samia, Ayuso, Guillermo Izquierdo, Eichau, Sara, Scott, Jeannette Lechner, McGuigan, Christopher, Prat, Alexandre ... Fistravec, Gregor (2025). Disease-Modifying Treatment Cessation or Switch Due to Pregnancy Planning in Women with MS: Is It Safe?. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Real-world Experience with Cladribine Tablets in the MSBase Registry 2025 UpdateSpelman, Tim, van der Walt, Anneke, Ozakbas, Serkan, Horakova, Dana, Alroughani, Raed, Kalincik, Tomas, Boz, Cavit, Buzzard, Katherine, Kermode, Allan, Gerlach, O., Foschi, Matteo, Jakob, Gregor Brecl, Grigoriadis, Nikolaos, Prevost, Julie, Duquette, Pierre, Lapointe, Emmanuelle, D'Amico, Emanuele, Ampapa, Radek, Gross-Paju, Katrin, Grammond, Pierre, Cardenas-Robledo, Simon, Houskova, Jana, Khoury, Samia, Maimone, Davide, Sanchez, Jose Luis, McCombe, Pamela, Slee, Mark, Taylor, Bruce, Blanco, Yolanda ... Butzkueven, Helmut (2025). Real-world Experience with Cladribine Tablets in the MSBase Registry 2025 Update. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Single silent lesions matter: a comprehensive assessment of the prognostic impact of clinically silent MRI lesions in RRMS, and an emulated trial of treatment escalationDaruwalla, Cyrus, Kremler, Courtney, Patti, Francesco, Libertinova, Jana, Ozakbas, Serkan, Peterka, Marek, Vachova, Marta, Boz, Cavit, Scott, Jeannette Lechner, Roos, Izanne, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Khoury, Samia, van der Walt, Anneke, Butzkueven, Helmut, Meca-Lallana, Jose E., Rous, Zuzana, Habek, Mario, Alroughani, Raed, Grammond, Pierre, Blanco, Yolanda, Laureys, Guy, Buzzard, Katherine, Skibina, Olga, Gray, Orla, Mccombe, Pamela, Izquierdo Ayuso, Guillermo, Eichau, Sara ... Brown, William (2025). Single silent lesions matter: a comprehensive assessment of the prognostic impact of clinically silent MRI lesions in RRMS, and an emulated trial of treatment escalation. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Stronger Together: Bayesian Evidence from Four Countries Reinforces Early High-Efficacy Treatment in Multiple SclerosisStastna, Dominika, Horakova, Dana, Drahota, Jiri, Mazouchova, Aneta, Kovarova, Ivana, Barnett, Michael, Kalincik, Tomas, Buzzard, Katherine, van der Walt, Anneke, Macdonell, Richard, Scott, Jeannette Lechner, John, Nevin A., Mccombe, Pamela, Hodgkinson, Suzanne, Taylor, Bruce, Slee, Mark, Garber, Justin, Havrdova, Eva, Vachova, Marta, Ampapa, Radek, Libertinova, Jana, Houskova, Jana, Recmanova, Eva, Dufek, Michal, Mares, Miroslav, Hradilek, Pavel, Rous, Zuzana, Pavelek, Zbysek, Stetkarova, Ivana ... Fistravec, Gregor (2025). Stronger Together: Bayesian Evidence from Four Countries Reinforces Early High-Efficacy Treatment in Multiple Sclerosis. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Safety-Driven Ocrelizumab Discontinuation vs Continuation: Comparative Insights from MSBaseD'Amico, Emanuele, Zanghi, Aurora, Spelman, Tim, Kermode, Allan G., Pedrini, Marzena, Carroll, William, Lechner-Scott, Jeannette, van der Walt, Anneke, Butzkueven, Helmut, John, Nevin A., Kalincik, Tomas, Roos, Izanne, Boz, Cavit, Ozakbas, Serkan, Barnett, Michael, Hodgkinson, Suzanne, Habek, Mario, Buzzard, Katherine, Skibina, Olga, Grammond, Pierre, Alroughani, Raed, Laureys, Guy, Horakova, Dana, Havrdova, Eva, Izquierdo, Guillermo H., Eichau, Sara, Mccombe, Pamela, Massey, Jennifer, Aragon de Vecino, Maria Cecilia ... Gerlach, Oliver (2025). Safety-Driven Ocrelizumab Discontinuation vs Continuation: Comparative Insights from MSBase. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Real-World Management of Multiple Sclerosis after Cancer ChemotherapyNesbitt, Cassie, Sanfilippo, Paul, Zhu, Chao, Ozakbas, Serkan, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Kalincik, Tomas, Roos, Izanne, Buzzard, Katherine, Skibina, Olga, Foschi, Matteo, Surcinelli, Andrea, Boz, Cavit, Scott, Jeannette Lechner, Libertinova, Jana, Patti, Francesco, Kermode, Allan, Carroll, William, Barnett, Michael, Hodgkinson, Suzanne, Grand'Maison, Francois, Horakova, Dana, Havrdova, Eva, Blanco, Yolanda, Hradilek, Pavel, Vachova, Marta, Habek, Mario, Maimone, Davide ... Jokubaitis, Vilija (2025). Real-World Management of Multiple Sclerosis after Cancer Chemotherapy. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Treatment strategies after cell-trafficking agents in MS patients older than 50 yearsMuller, Jannis, Benkert, Pascal, Horakova, Dana, Havrdova, Eva, Buzzard, Katherine, Skibina, Olga, Ozakbas, Serkan, Lechner Scott, Jeannette, Izquierdo Ayuso, Guillermo, Eichau, Sara, Weinstock-Guttman, Bianca, Hodgkinson, Suzanne, Grammond, Pierre, Barnett, Michael, Prat, Alexandre, Girard, Marc, Duquette, Pierre, van der Walt, Anneke, Butzkueven, Helmut, John, Nevin A., Meca-Lallana, Jose E., Prevost, Julie, Gerlach, O., Boz, Cavit, McCombe, Pamela, Lugaresi, Alessandra, Tomassini, Valentina, Kermode, Allan, Pedrini, Marzena ... Roos, Izanne (2025). Treatment strategies after cell-trafficking agents in MS patients older than 50 years. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?Foong, Yi Chao, Merlo, Daniel, Gresle, Melissa, Buzzard, Katherine, Horakova, Dana, Havrdova, Eva, Kalincik, Tomas, Roos, Izanne, Hodgkinson, Suzanne, Scott, Jeannette Lechner, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Ozakbas, Serkan, Surcinelli, Andrea, Foschi, Matteo, Boz, Cavit, Khoury, Samia, Yamout, Bassem, Laureys, Guy, Blanco, Yolanda, Skibina, Olga, Kuhle, Jens, John, Nevin A., Alroughani, Raed, Prevost, Julie, Van Pesch, Vincent, Tomassini, Valentina, Prat, Alexandre, Terzi, Murat ... van der Walt, Anneke (2025). Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Machine Learning-Generated Longitudinal Synthetic International Data in Multiple SclerosisIqbal, Hassam, Qiang, Zhe, Sharmin, Sifat, Ball, Gareth, Brankovic, Aida, Horakova, Dana, Havrdova, Eva, Ozakbas, Serkan, Shaygannejad, Vahid, Karabudak, Rana, Patti, Francesco, Zamzam, Dina, Alroughani, Raed, Etemadifar, Masoud, Boz, Cavit, Ayuso, Guillermo Izquierdo, Eichau, Sara, Terzi, Murat, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Amato, Maria Pia, Grand'Maison, Francois, Kermode, Allan, Pedrini, Marzena, Carroll, William, Yamout, Bassem I., Khoury, Samia, Shalaby, Nevin ... Kalincik, Tomas (2025). Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Effectiveness of autologous haematopoietic stem cell transplant in comparison with anti-CD20 therapies in relapsing-remitting multiple sclerosisKalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S., Atkins, Harold, Massey, Jennifer, Sutton, Ian, Withers, Barbara, Burman, Joachim, Torkildsen, Oivind, Bo, Lars, Lehmann, Anne Kristine, Havrdova, Eva, Krasulova, Eva, Trneny, Marek, Kozak, Tomas, Macdonell, Richard, Brown, J. William L., Coles, Alasdair, van der Walt, Anneke, Butzkueven, Helmut, Scott, Jeannette Lechner, Van Wijmeersch, Bart, Barnett, Michael, Laureys, Guy, Willekens, Barbara, Buzzard, Katherine, Skibina, Olga, Di Gregorio, Maria ... Snowden, John (2025). Effectiveness of autologous haematopoietic stem cell transplant in comparison with anti-CD20 therapies in relapsing-remitting multiple sclerosis. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Real-World Insights on Ofatumumab in Australian RMS Patients: MSBase Registry AnalysisButzkueven, Helmut, van der Walt, Anneke, Spelman, Tim, Kermode, Allan, Pedrini, Marzena, Carroll, William, Scott, Jeannette Lechner, John, Nevin A., Barnett, Michael, Hodgkinson, Suzanne, McCombe, Pamela, Kalincik, Tomas, Macdonell, Richard, Slee, Mark, Buzzard, Katherine, Nelson, Morag, Schmitt, Birte and Martel, Kate (2025). Real-World Insights on Ofatumumab in Australian RMS Patients: MSBase Registry Analysis. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Causal effects of multiple sclerosis therapies in left-truncated registry dataHaile, Dagmawi, Diouf, Ibrahima, Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva, Patti, Francesco, Izquierdo Ayuso, Guillermo, Eichau, Sara, Alroughani, Raed, Lugaresi, Alessandra, Tomassini, Valentina, Boz, Cavit, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Buzzard, Katherine, Skibina, Olga, Yamout, Bassem I., Terzi, Murat, Khoury, Samia, Grammond, Pierre, Scott, Jeannette Lechner, Blanco, Yolanda, Shaygannejad, Vahid, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Weinstock-Guttman, Bianca, Prevost, Julie ... Kalincik, Tomas (2025). Causal effects of multiple sclerosis therapies in left-truncated registry data. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication From Data to Diagnosis: Harmonizing RRMS and SPMS Classification via AI Models on Global and National ScalesSreenivasan, Akshai Parakkal, Sharmin, Sifat, Noui, Yassine, Ozakbas, Serkan, Etemadifar, Masoud, Alroughani, Raed, Shaygannejad, Vahid, Patti, Francesco, Boz, Cavit, Brown, J. William L., Coles, Alasdair, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Yamout, Bassem I., Khoury, Samia, Ayuso, Guillermo Izquierdo, Eichau, Sara, Terzi, Murat, Roos, Izanne, Scott, Jeannette Lechner, Buzzard, Katherine, Skibina, Olga, Grammond, Pierre, Habek, Mario, Zakaria, Magd Fouad, Amato, Maria Pia, Prevost, Julie, Gerlach, O. ... Kultima, Kim (2025). From Data to Diagnosis: Harmonizing RRMS and SPMS Classification via AI Models on Global and National Scales. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Cladribine as an exit strategy in people with MS over the age of 50Roos, Izanne, Sharmin, Sifat, Mueller, Jannis, Horakova, Dana, Havrdova, Eva, Ozakbas, Serkan, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Libertinova, Jana, Mares, Miroslav, Grammond, Pierre, Prevost, Julie, Rous, Zuzana, Scott, Jeannette Lechner, Buzzard, Katherine, Skibina, Olga, Hradilek, Pavel, van der Walt, Anneke, Butzkueven, Helmut, Boz, Cavit, Patti, Francesco, Barnett, Michael, Izquierdo Ayuso, Guillermo, Eichau, Sara, Blanco, Yolanda, Meca-Lallana, Jose E., Foschi, Matteo, Surcinelli, Andrea ... Kalincik, Tomas (2025). Cladribine as an exit strategy in people with MS over the age of 50. LONDON: SAGE PUBLICATIONS LTD. |
